ArticleContemporary clinical trials communications2020

Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial.

Christian Pfister et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.